Literature DB >> 17131329

Loss of chromosomal integrity drives rat mammary tumorigenesis.

Thea M Goepfert1, Myrthala Moreno-Smith, David G Edwards, Sen Pathak, Daniel Medina, W R Brinkley.   

Abstract

Breast cancer incidence varies with diet and other environmental influences, including carcinogen exposure. However, the effects of carcinogens on cell growth control pathways are poorly understood. Here, we have examined processes that are activated in the mammary glands of rats treated with 1-methyl-1-nitrosourea (MNU). This synthetic carcinogen was used to study events occurring during mammary tumor initiation and development. In female Wistar-Furth rats, given 1 dose of MNU beginning at 50 days of age, 84% of the rats developed tumors by 46 weeks of age (latency 13-15 weeks). Changes in the gland occurred as early as 1-day post-MNU. Cells exhibited DNA damage, leading to chromosomal instability, supernumerary centrosomes and higher levels of Aurora A; these events correlated with the appearance of preneoplasia in the glands. In mammary tumors, elevated numbers of centrosomes coincided with genomic instability. Tumors were transplanted into syngeneic hosts and subsequent tumor generations displayed the same marker chromosomes in mostly aneuploid metaphases with hyperdiploid numbers of chromosomes, suggesting that clonality and aneuploidy were passed on from one generation to the next. Collectively, these data suggest that the carcinogen MNU induces changes resulting in genetic instability detectable before hyperplasia and tumors develop in the rat mammary gland. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17131329     DOI: 10.1002/ijc.22420

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

Review 1.  Centrosome amplification: a suspect in breast cancer and racial disparities.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Endocr Relat Cancer       Date:  2017-05-17       Impact factor: 5.678

Review 2.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

3.  The G1 phase Cdks regulate the centrosome cycle and mediate oncogene-dependent centrosome amplification.

Authors:  Mary K Harrison; Arsene M Adon; Harold I Saavedra
Journal:  Cell Div       Date:  2011-01-27       Impact factor: 5.130

Review 4.  Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer.

Authors:  Katrina M Piemonte; Lindsey J Anstine; Ruth A Keri
Journal:  Endocrinology       Date:  2021-12-01       Impact factor: 5.051

5.  Karyotypic evolutions of cancer species in rats during the long latent periods after injection of nitrosourea.

Authors:  Mathew Bloomfield; Amanda McCormack; Daniele Mandrioli; Christian Fiala; C Marcelo Aldaz; Peter Duesberg
Journal:  Mol Cytogenet       Date:  2014-12-16       Impact factor: 2.009

6.  Programmed Minichromosome Elimination as a Mechanism for Somatic Genome Reduction in Tetrahymena thermophila.

Authors:  Chih-Yi Gabriela Lin; I-Ting Lin; Meng-Chao Yao
Journal:  PLoS Genet       Date:  2016-11-02       Impact factor: 5.917

7.  Speciation Theory of Carcinogenesis Explains Karyotypic Individuality and Long Latencies of Cancers.

Authors:  Ankit Hirpara; Mathew Bloomfield; Peter Duesberg
Journal:  Genes (Basel)       Date:  2018-08-09       Impact factor: 4.096

8.  Histological analysis of low dose NMU effects in the rat mammary gland.

Authors:  Tessa J Murray; Angelo A Ucci; Maricel V Maffini; Carlos Sonnenschein; Ana M Soto
Journal:  BMC Cancer       Date:  2009-08-03       Impact factor: 4.430

9.  Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells.

Authors:  Mateusz Opyrchal; Jeffrey L Salisbury; Shuya Zhang; James McCubrey; John Hawse; Mattew P Goetz; Gwen A Lomberk; Tufia Haddad; Amy Degnim; Carol Lange; James N Ingle; Evanthia Galanis; Antonino B D'Assoro
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

Review 10.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Authors:  Jessica S Helm; Ruthann A Rudel
Journal:  Arch Toxicol       Date:  2020-05-13       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.